Degradable thermoresponsive poly(ethylene glycol) analogue materials
AssigneeUniversity of Wyoming
InventorsMaciej Radosz, Youqing Shen
Life of this patent
Estimating the term…
Abstract
A method of developing degradable linear poly(ethylene glycol) PEG (DPEG) with multiple functioning capacities, which can be used as drug carriers for cancer cell delivery. A DPEG may be effective in targeting cancerous tumors through an enhanced permeation and retention effect (EPR). The DPEG will then degrade in the acidic extracellular fluid of solid tumors leading to fast cellular internalizations, finally degrading in the lysosome for efficient renal clearance. These may be used in conjunction with drugs and/or targeting groups. Furthermore, DPEGs are thermoresponsive, on an as needed basis, making them useful for in vivo application.
Claims7
A method for making poly(ethylene glycol) (PEG) analogues, comprising reacting PEG-di(meth)acrylates or di(meth)acrylamides with dithiols.
A method for making poly(ethylene glycol) (PEG) analogues, comprising reacting PEG-diols or PEG-diamines with dianhydrides.
Dependencies are inferred from the claim text.